INCREASED VASCULAR-PERMEABILITY IN ORGANS MEDIATED BY THE SYSTEMIC ADMINISTRATION OF LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 IN MICE

被引：130
作者：
ETTINGHAUSEN, SE [1 ]
PURI, RK [1 ]
ROSENBERG, SA [1 ]
机构：
[1] NCI, DIV CANC TREATMENT, SURG BRANCH, BLDG 10, RM 2B58, BETHESDA, MD 20892 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1988年 / 80卷 / 03期
关键词：
D O I：
10.1093/jnci/80.3.177
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：177 / 188
页数：12
相关论文
共 52 条
[1]   T-CELL-DEPENDENT MAST-CELL DE-GRANULATION AND RELEASE OF SEROTONIN IN MURINE DELAYED-TYPE HYPERSENSITIVITY [J].
ASKENASE, PW ;
BURSZTAJN, S ;
GERSHON, MD ;
GERSHON, RK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (05) :1358-1374
[2]   THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO [J].
COBBOLD, SP ;
JAYASURIYA, A ;
NASH, A ;
PROSPERO, TD ;
WALDMANN, H .
NATURE, 1984, 312 (5994) :548-551
[3]   MONOCLONAL-ANTIBODIES TO PROMOTE MARROW ENGRAFTMENT AND TISSUE GRAFT TOLERANCE [J].
COBBOLD, SP ;
MARTIN, G ;
QIN, S ;
WALDMANN, H .
NATURE, 1986, 323 (6084) :164-166
[4]  
DAMLE NK, 1987, J IMMUNOL, V138, P1779
[5]   CHARACTERIZATION OF THE MURINE ANTIGENIC DETERMINANT, DESIGNATED L3T4A, RECOGNIZED BY MONOCLONAL-ANTIBODY GK1.5 - EXPRESSION OF L3T4A BY FUNCTIONAL T-CELL CLONES APPEARS TO CORRELATE PRIMARILY WITH CLASS II MHC ANTIGEN-REACTIVITY [J].
DIALYNAS, DP ;
WILDE, DB ;
MARRACK, P ;
PIERRES, A ;
WALL, KA ;
HAVRAN, W ;
OTTEN, G ;
LOKEN, MR ;
PIERRES, M ;
KAPPLER, J ;
FITCH, FW .
IMMUNOLOGICAL REVIEWS, 1983, 74 :29-56
[6]  
ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P1488
[7]  
ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P3623
[8]  
GABBIANI G, 1970, P SOC EXP BIOL MED, V135, P447
[9]  
GECZY CL, 1984, SPRINGER SEMIN IMMUN, V7, P321
[10]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .3. EVIDENCE THAT IL-2 IS SUFFICIENT FOR DIRECT ACTIVATION OF PERIPHERAL-BLOOD LYMPHOCYTES INTO LYMPHOKINE-ACTIVATED KILLER CELLS [J].
GRIMM, EA ;
ROBB, RJ ;
ROTH, JA ;
NECKERS, LM ;
LACHMAN, LB ;
WILSON, DJ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (04) :1356-1361
123456